clinical trial
The Multidisciplinary Association for Psychedelic Studies (MAPS) has achieved FDA approval for its Phase 2 clinical trial, MJP2, after three years of negotiations and regulatory hurdles. This study will investigate the use of smoked cannabis in treating PTSD among 320 veterans across multiple states, aiming to generate real-world safety data. Funded by the Michigan Veteran […]
A groundbreaking study from the University of Rochester Medical Center (URMC) on Hodgkin lymphoma has demonstrated a 92% survival rate, with fewer side effects and reduced use of radiation therapy. The study, led by Dr. Johnathan Friedberg and funded by the National Cancer Institute, involved around 1,000 pediatric and adult patients, marking the first U.S. […]
-
Pages
WDKX Holiday Stream